Recent Phase IV vaccine trials

Below is a list of phase IV trials performed since 2011, for trials conducted before, contact: cev@uantwerpen.be

A Phase 4 study to evaluate the safety and immunogenicity of monovalent oral polio vaccine type 2 in healthy OPV-vaccinated adults OPV-vaccinated adults

  • EudraCT number:2015-003325-33
  • Sponsor protocol number: UAM1
  • Phase: IV
  • Population age: adults (18 to 50y)
  • Gender: male, female
  • Starting year @CEV: 2016

A Phase 4 study to evaluate the safety and immunogenicity of trivalent oral polio vaccine in adults previously vaccinated with oral polio vaccine

  • EudraCT number:2015-003324-32
  • Sponsor protocol number: UAT1
  • Phase: IV
  • Population age: adults (18 to 50y)
  • Gender: male, female
  • Starting year @CEV: 2015